You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation

Article info

Article menu

Download PDFPDF

XML
Research Article
Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation

Authors

  • Hua Jing Department of Radiation OncologyMedical Center, Faculty of Medicine, University of Freiburg Freiburg Germany German Cancer Consortium (DKTK) Partner Site Freiburg Freiburg Germany German Cancer Research Center (DKFZ) Heidelberg Germany Innovent Biologics (Suzhou) Co., Ltd. Suzhou China PubMed articlesGoogle scholar articles
  • Michael Hettich Department of Radiation OncologyMedical Center, Faculty of Medicine, University of Freiburg Freiburg Germany Oncology Translational Imaging Science, Roche pRED Basel Switzerland PubMed articlesGoogle scholar articles
  • Simone Gaedicke Department of Radiation OncologyMedical Center, Faculty of Medicine, University of Freiburg Freiburg Germany PubMed articlesGoogle scholar articles
  • Elke Firat Department of Radiation OncologyMedical Center, Faculty of Medicine, University of Freiburg Freiburg Germany PubMed articlesGoogle scholar articles
  • Mark Bartholomä Department of Nuclear MedicineMedical Center, Faculty of Medicine, University of Freiburg Freiburg Germany PubMed articlesGoogle scholar articles
  • Gabriele Niedermann Department of Radiation OncologyMedical Center, Faculty of Medicine, University of Freiburg Freiburg Germany German Cancer Consortium (DKTK) Partner Site Freiburg Freiburg Germany German Cancer Research Center (DKFZ) Heidelberg Germany PubMed articlesGoogle scholar articles

Citation

Jing H, Hettich M, Gaedicke S, et al
Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation
Journal for ImmunoTherapy of Cancer 2019;7:55. doi: 10.1186/s40425-019-0537-9
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.